• Kedrion Developing Plasma Therapy for COVID-19 contractpharma
    April 09, 2020
    Kedrion Biopharma, an Italian biotech company, has started the development of a plasma-derived therapy for treating the COVID-19 virus that could make it available to patients.
PharmaSources Customer Service